Amundi Sells 137,419 Shares of Encompass Health Co. (NYSE:EHC)

Amundi reduced its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 41.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 192,272 shares of the company's stock after selling 137,419 shares during the period. Amundi owned 0.19% of Encompass Health worth $17,851,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. TD Private Client Wealth LLC raised its position in shares of Encompass Health by 2,870.0% during the third quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company's stock worth $709,000 after acquiring an additional 7,089 shares during the last quarter. Pathstone Holdings LLC increased its position in Encompass Health by 54.5% during the 3rd quarter. Pathstone Holdings LLC now owns 21,022 shares of the company's stock valued at $2,032,000 after purchasing an additional 7,412 shares during the period. Meeder Asset Management Inc. raised its holdings in Encompass Health by 43.8% during the 3rd quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company's stock worth $6,417,000 after purchasing an additional 20,242 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Encompass Health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company's stock worth $161,781,000 after purchasing an additional 20,547 shares during the period. Finally, Central Pacific Bank Trust Division boosted its stake in shares of Encompass Health by 15.1% in the 4th quarter. Central Pacific Bank Trust Division now owns 3,195 shares of the company's stock valued at $295,000 after purchasing an additional 418 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Insider Activity at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of the company's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. This represents a 6.79 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 2.10% of the stock is currently owned by insiders.

Encompass Health Stock Up 1.8 %

Shares of NYSE:EHC traded up $1.75 during trading on Monday, reaching $97.73. 575,468 shares of the stock were exchanged, compared to its average volume of 633,969. The stock has a fifty day moving average of $97.35 and a two-hundred day moving average of $96.97. Encompass Health Co. has a 1-year low of $74.45 and a 1-year high of $104.55. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The firm has a market cap of $9.84 billion, a price-to-earnings ratio of 21.91, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Research analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.70%. Encompass Health's dividend payout ratio (DPR) is currently 15.25%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on EHC shares. KeyCorp lifted their target price on shares of Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research note on Monday, February 10th. Royal Bank of Canada reissued an "outperform" rating and issued a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a research report on Saturday, February 15th. Barclays lifted their target price on Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, February 7th. Finally, William Blair restated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Ten investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, Encompass Health has an average rating of "Buy" and a consensus target price of $107.67.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.